Siblia
Phage Display Vaccines: New Possibilities for Antigen Presentation and Vaccine Research
A 2026 study of a lambda phage platform targeting EGFRvIII highlights the potential of multivalent antigen display, while underscoring the challenges of translating experimental vaccine designs into effective immunization strategies. What the 2026 EGFRvIII Study Demonstrated In March 2026, NIH-affiliated scientists reported a lambda (λ) bacteriophage engineered to display an...
218 Προβολές
© 2026 Siblia Σε σύνδεση: 1 Σήμερα: 377 Yesterday: 274 This Week: 602 This Month: 602 This Year: 602 Σύνολο: 602 Visitor Analytics